0 CHECKOUT

Analgesics in Brazil

  • ID: 224151
  • April 2015
  • Region: Brazil
  • 36 pages
  • Euromonitor International

Accounting for exactly a third of overall OTC value sales in 2014, analgesics was the second most important category within consumer health in Brazil in 2014, behind cough, cold and allergy (hay fever) remedies. Value sales of analgesics in Brazil increased by 11% in current value terms in this same year, to reach BRL4,572 million. This performance was slightly weaker than that registered in the review period, when the category grew by a CAGR of 13% in current value terms.

The Analgesics in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown

ANALGESICS IN BRAZIL

April 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2009-2014
Table 2 Sales of Analgesics by Category: % Value Growth 2009-2014
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2009-2014
Table 4 NBO Company Shares of Analgesics: % Value 2010-2014
Table 5 LBN Brand Shares of Analgesics: % Value 2011-2014
Table 6 Forecast Sales of Analgesics by Category: Value 2014-2019
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2014-2019
Aché Laboratórios Farmacêuticos SA in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 1 Aché Laboratórios Farmacêuticos SA: Key Facts
Summary 2 Aché Laboratórios Farmacêuticos SA: Operational Indicators
Company Background
Production
Summary 3 Aché Laboratórios Farmacêuticos SA: Production Statistics 2014
Competitive Positioning
Summary 4 Aché Laboratórios Farmacêuticos SA: Competitive Position 2014
Bayer (brasil) SA in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 5 Bayer (Brasil) SA: Key Facts
Summary 6 Bayer (Brasil) SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 7 Bayer (Brasil) SA: Competitive Position 2014
Boehringer Ingelheim Do Brasil Química E Farmacêutica Ltda in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 8 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Key Facts
Company Background
Production
Summary 9 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Production Statistics 2014
Competitive Positioning
Summary 10 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive Position 2014
Hypermarcas SA in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 11 Hypermarcas SA: Key Facts
Summary 12 Hypermarcas SA: Operational Indicators
Company Background
Production
Summary 13 Hypermarcas SA: Production Statistics 2014
Competitive Positioning
Summary 14 Hypermarcas SA: Competitive Position 2014
Sanofi-aventis Farmacêutica Ltda in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 15 Sanofi-Aventis Farmacêutica Ltda: Key Facts
Company Background
Production
Summary 16 Sanofi-Aventis Farmacêutica Ltda: Production Statistics 2014
Competitive Positioning
Summary 17 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2014
Executive Summary
Improper Self-medication Culture Restricts OTC Sales Growth in Brazil
New Anvisa Regulation Allows Interchangeability Between Similar Medications and Generics
Negative Media Hampers the Growth of Local Sports Nutrition Brands
Continued Investment in Private Label by Chemists/pharmacies
Brazil Witnesses A Slowdown in OTC Consumption During the 2014 Fifa World Cup
Key Trends and Developments
Improper Self-medication Culture Restricts OTC Sales Growth in Brazil
New Anvisa Regulation Allows Interchangeability Between Similar Medicines and Generics
Negative Media Hampers the Growth of Local Sports Nutrition Brands
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
Table 9 Life Expectancy at Birth 2009-2014
Market Data
Table 10 Sales of Consumer Health by Category: Value 2009-2014
Table 11 Sales of Consumer Health by Category: % Value Growth 2009-2014
Table 12 NBO Company Shares of Consumer Health: % Value 2010-2014
Table 13 LBN Brand Shares of Consumer Health: % Value 2011-2014
Table 14 Distribution of Consumer Health by Format: % Value 2009-2014
Table 15 Distribution of Consumer Health by Format and Category: % Value 2014
Table 16 Forecast Sales of Consumer Health by Category: Value 2014-2019
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 18 Research Sources

Note: Product cover images may vary from those shown

CH06anBR

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Johnson & Johnson Services, Inc.
  • Procter & Gamble Co.
  • Sanofi S.A.
  • GlaxoSmithKline PLC
  • Novartis AG
  • Pfizer, Inc.
  • Boehringer Ingelheim GmbH